“Big BioPharma needs growth,” says Wells Fargo analyst Mohit Bansal in a research note that anticipates a pick-up in smaller deals in the sector.
Signs point to biotech M&A heating up, Wells Fargo says. Here’s where to look
Share This Story, Choose Your Platform!
About the Author: David Hilbern
